T A B L E O F C O N T E N

Main results
Three studies (a total of 112 participants) were included. All studies randomised participants to a singing group or a control group. The comparison groups included a film workshop, handcraft work, and no intervention. The frequency of the singing intervention in the studies ranged from 1 to 2 times a week over a 6 to 24 week period. The duration of each singing session was 60 minutes.
All studies included participants diagnosed with COPD with a mean age ranging from 67 to 72 years and a mean forced expiratory volume in one second (FEV 1 ) ranging from 37% to 64% of predicted values. The sample size of included studies was small (33 to 43 participants) and overall study quality was low to very low. Blinding of personnel and participants was not possible due to the physical nature of the intervention, and selection and reporting bias was present in two studies.
For the primary outcome of health-related quality of life, there was no statistically significant improvement in the St George's Respiratory Questionnaire total score (mean difference (MD) -0.82, 95% confidence interval (CI) -4.67 to 3.02, 2 studies, n = 58, low-quality evidence). However, there was a statistically significant improvement in the SF-36 Physical Component Summary (PCS) score favouring the singing group (MD 12.64, 95% CI 5.50 to 19.77, 2 studies, n = 52, low-quality evidence). Only one study reported results for the other primary outcome of dyspnoea, in which the mean improvement in Baseline Dyspnoea Index (BDI) score favouring the singing group was not statistically significant (MD 0.40, 95% CI -0.65 to 1.45, 1 study, n = 30, very low-quality evidence).
No studies examined any long-term outcomes and no adverse events or side effects were reported.
Authors' conclusions
There is low to very low-quality evidence that singing is safe for people with COPD and improves physical health (as measured by the SF-36 physical component score), but not dyspnoea or respiratory-specific quality of life. The evidence is limited due to the low number of studies and the small sample size of each study. No evidence exists examining the long-term effect of singing for people with COPD. The absence of studies examining singing performed in conjunction with pulmonary rehabilitation precludes the formulation of conclusions about the effects of singing in this context. More randomised controlled trials with larger sample sizes and long-term follow-up, and trials examining the effect of singing in addition to pulmonary rehabilitation, are required to determine the effect of singing on health-related quality of life and dyspnoea in people with COPD.
P L A I N L A N G U A G E S U M M A R Y
Singing for COPD
Singing uses the lungs to provide airflow to produce musical words or sounds with the voice. Singing can require a lot of effort for muscle contraction and co-ordination. This may benefit people with chronic obstructive pulmonary disease (COPD) in a manner similar to that of breathing exercises. Singing is said to be beneficial for health but we need evidence for this before it can be recommended specifically to address health conditions. We planned to examine whether singing had any effect on quality of life or breathlessness in people with COPD. We included three studies with a total of 112 participants. Participants were randomly assigned to singing training or to a non-singing control group. The control groups were either a film workshop, handcraft work, or nothing at all. The singing was performed in groups, once to twice a week for one hour, for a minimum of six weeks. There was diversity in the results of the studies and we were unable to combine many results in 'meta-analyses'. A meta-analysis is a statistical analysis which combines the results of two or more separate studies to give a pooled result. Some studies showed improvements in some aspects of quality of life, while others showed no improvement. Breathlessness was only measured in one study and no improvement was found. The studies did not report whether any effects lasted for a long time after the singing training was completed. No studies reported any side effects from singing, so singing appears to be safe for people with COPD. The studies were of low quality due to the small number of participants and missing information about the methods and some of the outcomes. We were unable to find enough evidence to sufficiently determine the effect of singing in people with COPD. More studies are required and they should concentrate on enrolling larger numbers of people.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Singing compared with control for chronic obstructive pulmonary disease (COPD) The m ean change in SGRQ (total score) ranged across control groups f rom -5.0 to -0.4
The m ean change in SGRQ (total score) in the intervention groups was 0.8 units higher (3. 0 units lower to 4.7 units higher) 58 (2 studies)
The m inim al im portant dif f erence is 4 units lower
Health-related quality of life (generic) SF-36 (Physical Component Sum m ary (PCS) score)
The m ean change in SF-36 (PCS score) ranged across control groups f rom -3.8 to -2.5
The m ean change in SF-36 (PCS score) in the intervention groups was 12.6 units higher (5. 5 units higher to 19.8 52 (2 studies)
The m inim al im portant dif f erence is 4 units higher The m inim al im portant dif f erence is 4 units higher
Dyspnoea
Basal Dyspnea Index (BDI) (score) Scale f rom 0-12 Higher value post intervention is f avourable, indicating im provem ent in dyspnoea Follow-up: end of intervention (24 weeks)
The m ean change in BDI (score) was 0.3
The m ean change in BDI (score) in the intervention groups was 0.4 units higher (0.7 units lower to 1.5 units higher)
30
(1 study)
B A C K G R O U N D Description of the condition
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterised by airflow limitation that is not fully reversible and is associated with an abnormal inflammatory response of the lungs to noxious particles or gases (GOLD 2017). The prevalence of COPD has been reported as ranging from 0.2% to 37%, and varies widely across countries and populations (Rycroft 2012). Prevalence and incidence is greatest in men and those aged 75 years and over (Rycroft 2012). COPD is a major cause of morbidity and is the third most common cause of death globally (Lozano 2012 
Description of the intervention
Singing is the production of musical words or sounds with the voice (Oxford 2016). Singing can be performed individually or in a group (choir), and can be arranged or improvised. Singing is a much more complex physical activity than speaking due to the greater length of phrases and greater range of pitch required (Irons 2010). Singing is dependent on the use of the lungs for air supply. During normal tidal breathing, the diaphragm contracts for inhalation, while exhalation occurs passively. During singing, air flow must be regulated and larger lung volumes are required, thus exhalation is active and aided by the abdominal, internal intercostal and pelvic muscles. Singing requires a high degree of muscle co-ordination by highly developed muscle reflexes. 
How the intervention might work
Singing is an activity that has the potential to improve health outcomes, such as relieving dyspnoea and enhancing quality of life, in people with COPD due to employment of diaphragmatic breathing, altered posture, and improved breathing co-ordination. 
Why it is important to do this review
Singing may have the potential to improve health outcomes in people with COPD. Systematic reviews of research literature have been completed for singing in other chronic respiratory diseases such as bronchiectasis (Irons 2010), and cystic fibrosis (Irons 2016), and found an absence of randomised controlled trials (RCTs) to support or refute the benefits of singing. However, the authors of these reviews found studies that reported an improvement in quality of life in people with COPD, and a systematic review of singing for COPD has not yet been carried out. Furthermore, whilst pulmonary rehabilitation improves physical and psychosocial health outcomes in people with COPD (McCarthy 2015), the potential additional benefits of adding singing to pulmonary rehabilitation has not been examined.
O B J E C T I V E S
To determine the effect of singing on health-related quality of life and dyspnoea in people with COPD.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) reported as fulltext, published as abstract only, and unpublished data. We used data from studies published as abstract only where authors provided study data. Where the data were not available, we recorded the studies as awaiting classification.
Types of participants
We included studies that involved adults with COPD, diagnosed according to the investigators' definition, of any age or disease severity. The COPD was required to be stable (i.e. optimal and stable respiratory medications with no exacerbation or hospitalisation within the previous month). We included participants with COPD who used supplemental oxygen. Participants with and without a history of singing training could be included, and we recorded the singing training history wherever possible.
Types of interventions
We included studies examining structured, supervised singing training of at least four weeks' duration with a minimum of four sessions. Studies were included that compared: 1. singing versus no intervention (usual care) or another control intervention;
2. singing plus pulmonary rehabilitation versus pulmonary rehabilitation alone. The singing could be performed individually or as part of a group (choir) facilitated by a singing leader, and inpatient and outpatient programmes were included. In the case of interventions combining one or more components of music therapy, for example instrumental and singing training, the singing needed to form the majority of the intervention. We recorded the precise nature of the singing facilitators' professional backgrounds, singing training and any pulmonary rehabilitation programme (frequency, duration, type, intensity), wherever possible.
Types of outcome measures
Primary outcomes
1. Health-related quality of life, measured using total scores from either generic or respiratory-specific quality-of-life questionnaires.
2. Dyspnoea, measured using a dyspnoea scale (e.g. Medical Research Council (MRC) dyspnoea scale (Bestall 1999)) or dyspnoea scores from a respiratory-specific quality-of-life questionnaire (e.g. dyspnoea domain of the Chronic Respiratory Disease Questionnaire (Guyatt 1987)), or both.
Secondary outcomes
1. Respiratory muscle strength measured from a pressure gauge (e.g. maximal inspiratory and expiratory mouth pressures or maximal sniff nasal inspiratory pressure).
2. Pulmonary function measured by spirometry or plethysmography (e.g. forced expiratory volume in one second (FEV 1 ) measured in litres or as per cent of predicted, forced vital capacity (FVC), FEV 1 /FVC ratio, total lung capacity (TLC), residual capacity (RC), functional residual capacity (FRC)).
3. Psychological status measured from generic psychological questionnaires or scales (e.g. Hospital Anxiety and Depression Scale (Zigmond 1983)).
4. Functional exercise capacity measured from a functional exercise test.
5. Peak exercise capacity measured from a peak exercise test. 6. Endurance exercise capacity measured from an endurance exercise test.
7. Healthcare utilisation recorded as hospitalisation or length of hospital stay, or both.
8. Physical activity level from objective measurement tools (e.g. pedometers, accelerometers, multi-sensor devices).
9. Adverse events/side effects. Reporting one or more of the outcomes listed here in the study was not an inclusion criterion for the review. We reviewed primary and secondary outcomes at baseline and immediately following the intervention period. If outcomes were also measured in the long term (e.g. six or 12 months after completion of intervention), we reviewed each of these time points in addition to immediately following the intervention period. The selected primary outcome measures are important to patients and clinicians, and all outcome measures were clinically relevant and could potentially be altered by a singing intervention.
Search methods for identification of studies Electronic searches
We identified trials from the Cochrane Airways Trials Register, which is maintained by the Information Specialist for the group. The Register contains studies identified from several sources:
1. 
Searching other resources
We checked reference lists of all primary studies and review articles for additional references. We searched for errata or retractions from included studies published in full-text on PubMed ( www.ncbi.nlm.nih.gov/pubmed).
Data collection and analysis
Selection of studies
Two review authors (RJM, CE) independently screened titles and abstracts of all the potential studies we identified as a result of the search and coded them as 'retrieve' (eligible or potentially eligible/ unclear) or 'do not retrieve'. We retrieved the full-text study reports or publications and two review authors (RJM, CE) independently screened the full text and identified studies for inclusion. They also identified and recorded reasons for excluding ineligible studies. We resolved any disagreement through discussion or we consulted a third review author (ZJM). We identified and excluded duplicates and collated multiple reports of the same study so that each study, rather than each report, was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram ( Figure 1 ) and 'Characteristics of excluded studies' table (Moher 2009).
Data extraction and management
We used a data collection form for study characteristics and outcome data. One review author (RJM) extracted study characteristics from included studies. A second review author (CE) spotchecked study characteristics for accuracy against the trial report. We extracted the following study characteristics:
1. methods: study design, total duration of study, details of any 'run-in' period, number of study centres and location, study setting, withdrawals and date of study; 2. participants: number, mean age, age range, gender, severity of condition, diagnostic criteria, baseline lung function, smoking history, inclusion criteria and exclusion criteria; 3. interventions: intervention, comparison, concomitant medications and excluded medications; 4. outcomes: primary and secondary outcomes specified and collected, and time points reported; 5. notes: funding for trial and notable conflicts of interest of trial authors. Two review authors (RJM, CE) independently extracted outcome data from included studies. One review author (RJM) transferred data into Review Manager 5 (RevMan 2014). We double-checked that data were entered correctly by comparing the data presented in the systematic review with the study reports.
Assessment of risk of bias in included studies
Two review authors (RJM, CE) independently assessed risk of bias for each study using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). We assessed the risk of bias according to the following domains:
1. random sequence generation; 2. allocation concealment; 3. blinding of participants and personnel; 4. blinding of outcome assessment; 5. incomplete outcome data; 6. selective outcome reporting; 7. other bias. We graded each potential source of bias as high, low or unclear and provided a quote from the study report together with a justification for our judgement in the 'Risk of bias' table. We summarised the 'Risk of bias' judgements across different studies for each of the domains listed. When considering treatment effects, we took into account the risk of bias for the studies that contributed to that outcome.
Assessment of bias in conducting the systematic review
We conducted this review according to the published protocol (Differences between protocol and review).
Measures of treatment effect
We analysed continuous data as mean differences (MDs). We entered data presented as a scale with a consistent direction of effect. We undertook meta-analyses only where this was meaningful, that is, if the treatments, participants and the underlying clinical question were similar enough for pooling to make sense. We narratively described skewed data reported as medians and interquartile ranges. Where multiple trial arms were reported in a single trial, we included only the relevant arms. If two comparisons were combined in the same meta-analysis, we halved the control group to avoid double counting.
Unit of analysis issues
We did not include cross-over trials. If the search identified cluster-randomised trials, the intention was to consult the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011), however no cluster-randomised trials were identified.
Dealing with missing data
We contacted investigators in order to verify key study characteristics and obtain missing numerical outcome data where possible (e.g. when a study was identified as abstract only).
Assessment of heterogeneity
We used the I 2 statistic to measure heterogeneity among the studies in each analysis. Heterogeneity was considered significant if the P value was less than 0.10 (Higgins 2011).
Assessment of reporting biases
We were unable to pool more than 10 studies, however if more studies are included in future review updates we will create and examine a funnel plot to explore possible small-study and publication biases.
Data synthesis
We used a random-effects model using Review Manager 5 (RevMan 2014) and used change from baseline results to final scores. Where the outcomes were reported using adjusted analyses (such as ANOVA or ANCOVA), we used the generic inverse variance method to combine the results with other studies; where adjusted analyses were not available, we preferred change from baseline results to final scores.
'Summary of findings' table
We created a 'Summary of findings' table using the following outcomes: health-related quality of life and dyspnoea. We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence as it related to the studies that contributed data to the meta-analyses for the prespecified outcomes. We used methods and recommendations described in Section 8.5 and Chapter 12 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011), and GRADEpro software (GRADEpro GDT). We justified all decisions to downgrade or upgrade the quality of studies using footnotes, and we have made comments to aid the reader's understanding of the review where necessary.
Subgroup analysis and investigation of heterogeneity
We planned to carry out the following subgroup analyses if sufficient studies were retrieved:
1. severity of lung disease -severe (FEV 1 % predicted less than 40%) versus not severe (FEV 1 % predicted 40% predicted or greater); 2. mode of singing intervention -individual versus group (choir); 3. participant's experience with singing training -no previous history with singing training versus prior history of singing training;
4. singing facilitator's professional background -formally trained music or singing professional versus health or lay professional. We planned to use the following outcomes in subgroup analyses:
1. health-related quality of life; 2. dyspnoea. We were unable to perform subgroup analyses due to the small number of studies. If more studies are included in future updates of this review, we will perform subgroup analyses using the formal test for subgroup interactions in Review Manager 5 (RevMan 2014).
Sensitivity analysis
We planned to carry out the following sensitivity analysis:
1. studies with a low risk of bias (to examine the effects of removing studies with a high risk of bias). We were unable to conduct this sensitivity analysis because of the small number of studies. If more studies are included in future review updates, a sensitivity analysis will be performed to analyse the effects of studies with a low risk of bias for at least three of the following domains: random sequence generation, allocation concealment, blinding of outcome assessment, and incomplete outcome data.
R E S U L T S Description of studies
Refer to the Characteristics of included studies, Characteristics of excluded studies and Characteristics of studies awaiting classification for the details of the studies included, excluded and awaiting classification.
Results of the search
Our search of the databases identified 50 citations. We identified three additional citations through handsearching. After removing duplicates, we reviewed 49 citation titles and abstracts, of which we excluded 38. We screened the full-text versions of eleven citations for eligibility, and excluded two because they did not meet the review inclusion criteria. Nine citations were appropriate for inclusion in the review, however one citation was published in abstract form only and our attempts to contact the authors were unsuccessful. This study remains as a study awaiting classification. The remaining eight citations represented three studies. We created a PRISMA flow diagram to depict the search results (Figure 1) . The review authors agreed on the inclusion of all citations, with a Cohen's kappa measurement of 1, indicating excellent agreement.
Included studies
We identified three studies (a total of 112 participants) which met the inclusion criteria for this review. They were represented by eight citations which were reviewed in full-text. The full details of these studies can be found in the Characteristics of included studies table. The sample size of studies ranged from 33 to 43 participants. All studies included participants diagnosed with chronic obstructive pulmonary disease (COPD), with a mean age ranging from 67 to 72 years and a mean forced expiratory volume in one second (FEV 1 ) ranging from 37% to 64% of predicted values. All studies randomised participants to a singing group or another control intervention. The frequency of the singing intervention in the studies ranged from 1 to 2 times a week over a 6 to 24 week period. The duration of the singing sessions was 60 minutes and they were conducted in groups led by a singing teacher. The singing sessions were structured in nature and included relaxation exercises, breathing exercises, vocalisation exercises, and singing. All studies began with relaxation exercises of the neck and upper limb muscles, or postural work and physical stretches. One study had participants perform singing-related breathing exercises consisting of fast, deep inspirations, followed by slow, full or interrupted expirations; performing fast and deep respiratory incursions, paying attention to the upper abdominal movements; and generating breathing movements against, or with the help of, pressures generated by a hand placed on the upper abdominal region (Bonilha 2009). All studies performed vocal exercises, for example, pronouncing vowels such as "le", "la", "mi", "mu", and singing the melody of a familiar song using such vowels instead of actually singing the lyrics ( The following secondary outcomes were not measured by the included studies: functional exercise capacity; endurance exercise capacity; and healthcare utilisation.
Excluded studies
We excluded two citations (representing one study) from this review due to the intervention not meeting the inclusion criteria.
Risk of bias in included studies
Our assessment of the risk of bias in the included studies is presented in Figure 2 and Figure 3 . 
Allocation
All three studies reported participant randomisation, however one study did not provide sufficient information to determine the sequence generation or allocation concealment (Bonilha 2009).
Blinding
Blinding of personnel and participants was not possible due to the physical nature of the intervention. Two studies reported blinding of the outcome assessor (Lord 2010; Lord 2012).
Incomplete outcome data
All three studies reported dropouts and loss to follow-up ranging from 22% to 30% (Bonilha 2009; Lord 2010; Lord 2012).
Selective reporting
Two studies reported all outcome measures as prespecified in the methods (Bonilha 2009; Lord 2010). One study did not report all outcomes at the post intervention time point as prespecified in the methods (Lord 2012).
Other potential sources of bias
All three studies appeared to be free of other sources of bias.
Effects of interventions
See: Summary of findings for the main comparison See Summary of findings for the main comparison. The Data and analyses table summarises the results of the metaanalyses for the comparison of singing to a control group. All three studies reported the results as change from baseline measures.
Primary outcomes
Health-related quality of life
Two studies reported results which could be pooled for metaanalysis for the St George's Respiratory Questionnaire (Bonilha 2009; Lord 2010). Results of the meta-analysis are shown in Figure  4 . There was no statistically significant improvement in the St George's Respiratory Questionnaire total score (mean difference (MD) -0.82, 95% confidence interval (CI) -4.67 to 3.02, n = 58). We assessed the quality of the evidence as low according to GRADE criteria (Summary of findings for the main comparison). 
Psychological status
Two studies reported results which could be pooled for metaanalysis for the Hospital Anxiety and Depression Scale (HADS) (Lord 2010; Lord 2012). There was no statistically significant improvement in the HADS anxiety score (MD -1.09, 95% CI -3.02 to 0.83, n = 52) or HADS depression score (MD -0.87, 95% CI -2.16 to 0.42, n = 52).
Functional exercise capacity
No studies measured functional exercise capacity.
Peak exercise capacity
Two studies reported results which could be pooled for metaanalysis using the Incremental Shuttle Walk Test (ISWT) (Lord 2010; Lord 2012). There is uncertainty due to imprecision about whether singing has an impact on ISWT distance (metres) compared to control (MD -9.26, 95% CI -43.10 to 24.57, n = 52).
Endurance exercise capacity
No studies measured endurance exercise capacity.
Healthcare utilisation
No studies measured healthcare utilisation or hospitalisation.
Physical activity level
One study (Lord 2012) reported measures of physical activity for 24 participants, including steps (steps per day), sedentary time (minutes per day), physical activity duration (minutes per day), and active energy expenditure (kJ per day). There were no statistically significant differences between the singing group and control group for sedentary time (minutes per day), but the confidence interval is wide (MD -8.60, 95% CI -88.33 to 71.13). There were statistically significant differences in the remaining measures of physical activity favouring the control group (steps (steps per day) MD -1774.00, 95% CI -2847.73 to -700.27; physical activity duration (minutes per day) MD -142.20, 95% CI -262.56 to -21.84; active energy expenditure (kJ per day) MD -373.00, 95% CI -625.28 to -120.72).
Adverse events and side effects
No adverse events or side effects were reported by any of the included studies, and participant withdrawal reasons (where provided) were unrelated to the singing intervention. The study by 
D I S C U S S I O N Summary of main results
We included three studies with a total of 112 participants in this review. The sample size of studies ranged from 33 to 43 participants. All studies included participants diagnosed with chronic obstructive pulmonary disease (COPD) with a mean age ranging from 67 to 72 years and mean forced expiratory volume in one second (FEV 1 ) ranging from 37% to 64% of predicted values. All studies randomised participants to a singing or a control group. Measures of pulmonary function and inspiratory muscle strength were only measured in one study and showed no significant differences between the singing group and control group. There was a statistically significant improvement in expiratory muscle pressure favouring the singing group, although this improvement was not clinically significant. No improvement in anxiety, depression, exercise capacity or physical activity level following singing were found. Healthcare utilisation was not measured by any studies and no adverse effects from singing were reported. There are no data to draw conclusions about the long-term effects of singing in people with COPD.
The main results show few statistically or clinically significant health outcomes. There were baseline imbalances between the studies, especially in lung function. This, along with the small number of participants, may have affected the precision around the mean differences. There is a clear need for larger trials with longer duration of follow-up to gain a better understanding of the effects of singing in people with COPD.
Overall completeness and applicability of evidence
Applicability of evidence includes consideration of whether people with COPD would be willing or motivated to participate in singing. Participants in the included studies were recruited from hospital respiratory clinics and no information was provided on previous experience of COPD management, such as pulmonary rehabilitation, or indeed of singing. A recent qualitative study found that people with COPD perceive that pulmonary rehabilitation does not fit their perception of health and that participation may be time-consuming and conflict with daily activities (Mathar 2017). It is not known whether singing might be considered similarly and what the impact of this might be on recruitment to a randomised controlled trial. Nonetheless, qualitative research studies have reported high satisfaction with singing by people with COPD, including self-reported improvements in both breathing and psychological outcomes (Goodridge 2013; Pacheco 2014; McNaughton 2016). This review included people with stable COPD of moderate to severe disease severity, therefore the results cannot be extrapolated to people with unstable disease such as during or following an exacerbation, or to people with milder COPD. The studies also only reported the short-term effects of singing. Without long-term studies, the effect of singing over a longer period of time cannot be determined. Furthermore, no healthcare utilisation data was reported in any of the selected studies which is particularly important in relation to commissioning and potential for incorporation of findings into healthcare guidelines in the future. Two studies randomised participants to an active comparison group which matched the time and attention of the singing group. However, the comparison group of one study provided no intervention. With an insufficient number of trials randomising participants to active and non-active comparison groups, we cannot determine whether any improvements in health outcomes were simply a result of participation in a group with support from a leader and fellow participants. From the data in this review, we cannot determine the optimal delivery mode or dosage of singing required to achieve positive health outcomes in people with COPD. The singing in each study was delivered by a singing teacher, however all studies delivered the singing in groups, so the effect of individual singing lessons in people with COPD cannot be ascertained. The frequency and duration of the singing programs ranged from once to twice a week, and from 6 to 24 weeks in length. It is unclear what frequency and duration is sufficient to provide an effective stimulus for learning the technique of singing and to have an effect on our health outcomes of interest. In all studies participants were instructed to practice their singing at home, however compliance was not measured, therefore it is unknown whether more frequent singing than the supervised group sessions may have contributed to some of the outcomes. There was general consistency in direction of effects in most out-comes. However, the outcome of anxiety showed an opposite effect. The results from Lord 2010 favoured singing, whilst Lord 2012 results favoured the control group. This inconsistency may be explained by the clinical heterogeneity of the two trials with baseline differences in lung function, anxiety, quality of life and exercise capacity, or it may simply be explained by the impact of chance on such small numbers of participants in each group. Whilst there was one clinically significant result for singing demonstrating an improvement in the SF-36 PCS score, the diversity in results for health-related quality of life may be explained by the methods employed by the studies. A primary outcome and sample size calculation was only reported by one of the included studies (Lord 2012). Therefore, we cannot determine whether two of the three included studies had an adequate sample size calculation or were adequately powered to determine a significant change for the outcome of health-related quality of life. There was a clinically significant change in physical activity favouring the control group in one study (Lord 2012) which is difficult to explain. No other health outcome was clinically significant, although the improvement in anxiety following singing showed a trend towards the minimal important difference (Puhan 2008). The small number of studies and small sample sizes are most likely the major reasons why the changes in outcomes in this review were so variable.
Quality of the evidence
The overall quality of the evidence for the studies included in this review was very low to low. The major methodological shortcoming was the small sample size of the studies. The quality of the evidence was also impacted by the inability to blind the population and personnel due to the physical nature of the intervention. An unknown randomisation process and lack of blinding of the outcome assessor compromised the quality of one study (Bonilha 2009), whilst a reporting bias was present in another study (Lord 2012) .
Potential biases in the review process
We adhered to the standard Cochrane methodological procedures to minimise bias, including having two authors independently screen trials, extract trial data and perform the 'Risk of bias' assessment. Attempts were made to contact trial authors where missing information was identified and for a study published in abstract form only, however data were not provided.
Agreements and disagreements with other studies or reviews
This findings of this Cochrane review are consistent with the overall findings of a recent review of singing for lung health in people with COPD (Lewis 2016). Cohort and qualitative data were also examined as part of the narrative literature review which found that participants generally reported positive impacts of singing on their activities of daily living such as housework, their ability to manage their breathlessness, and improved well-being (Lewis 2016). These findings are in agreement with the positive effects shown in this review for one aspect of health-related quality of life, even though the results of the meta-analyses with this small population did not demonstrate clinical significance for all healthrelated quality of life measures.
A U T H O R S ' C O N C L U S I O N S Implications for practice
There is limited low-quality evidence that singing is safe for people with moderate to severe COPD and improves physical health (as measured by the SF-36 physical component score). Whilst singing may be appealing and subjectively beneficial to some people with COPD, there is currently insufficient evidence to advocate singing as an effective intervention to achieve clinically significant health outcomes above and beyond no intervention or group-based recreational activities.
Implications for research
More randomised controlled trials are required to determine the effect of singing on health-related quality of life and dyspnoea in people with COPD; trials examining the effect of singing in addition to pulmonary rehabilitation are also needed. In particular, large studies with long-term follow-up are necessary. Future studies need to incorporate important methodological features such as adequate sample sizes, randomisation, allocation concealment and blinding of outcome assessors, as well as longer follow-up, to ensure high-quality evidence is available on the effectiveness of singing in people with COPD.
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